|WHO (OMS) Pandemic Information and Announcements
February 3rd, 2012, 10:14 AM
Membro del Comitato Consultivo, Editore e Direttore del Forum Italiano di FluTrackers
Join Date: Dec 2007
Location: Padua, Italy
Peer-reviewed literature - 03 February 2012 (WHO, edited): Corticosteroids and influenza pneumonia
[Source: World Health Organization, full page: (LINK
Peer-reviewed literature - 03 February 2012
Use of corticosteroids in patients with influenza pneumonia
The January 2012 issue of Journal of Infection contains a report by Diaz et al. which assessed the effect of treatment with corticosteroids on survival among patients with primary viral pneumonia due to influenza A(H1N1)pdm09. The study was conducted as a prospective, observational, multicenter study in 148 intensive care units (ICU) in Spain.
The inclusion criteria were influenza-like symptoms, acute respiratory failure requiring ICU admission, and microbiological confirmation of influenza A(H1N1)pdm09. ICU admission criterion was determined by the need for intubation. Primary viral pneumonia was defined as acute respiratory distress and unequivocal alveolar opacities involving two or more lobes, a positive reaction for influenza by real time polymerase chain reaction on a respiratory specimen, and negative bacterial cultures of respiratory tract and blood during the acute phase of influenza virus infection. Administration of corticosteroid, antibiotic, antiviral medicine, and intubation were not standardized. From a total of 968 patients with confirmed influenza A(H1N1)pdm09 virus infection, 372 with the diagnosis of primary viral pneumonia were analyzed. Of those, 136 patients (36.6%) received corticosteroids.
A Cox regression analysis adjusted for severity and potential confounding factors demonstrated that the use of corticosteroid therapy was not significantly associated with mortality (RR=1.06, 95% CI 0.63-1.80; p = 0.82).
The authors concluded that corticosteroid therapy in patients with primary viral pneumonia due to influenza A(H1N1)pdm09 does not improve survival.
Corticosteroids and other immune modulators have often been tried in the setting of influenza pneumonia and acute respiratory distress syndrome (ARDS) in an attempt to moderate the damage caused by the immune response.
Other investigators have found that corticosteroid administration may have deleterious effects. Martin-Loeches et al. found that early use of corticosteroids in patients admitted to the ICU due to influenza A(H1N1)pdm09 virus infection did not result in better outcomes and was associated with an increased risk of superinfections.
Brun-Buisson et al. also found no beneficial effect of corticosteroids in patients with ARDS secondary to influenza pneumonia and that very early corticosteroids therapy may be harmful.
Han et al reported early use of parenteral corticosteroids for pneumonia prevention increased the risk of critical disease or death from influenza A(H1N1)pdm09 infection.
Kim et al concluded that adjuvant corticosteroid therapy among patients admitted to ICU or requiring mechanical ventilation with influenza A(H1N1)pdm09 infection was associated with higher mortality and risk of superinfections.
Based on available data, WHO does not currently recommend the use of systemic high-dose corticosteroids for influenza-associated pneumonia. However, physiological replacement doses may be indicated in adrenocortical deficiency states and septic shock when hypotension is poorly responsive to fluid and vasopressor therapy.
Prolonged use of systemic high-dose corticosteroids can result in serious adverse events in influenza virus-infected patients, including opportunistic infection and possibly prolong viral replication.
However, it should be noted that there may be other influenza associated complications, such as influenza associated encephalopathy, where the benefit of corticosteriods may outweigh the risk. [7-9]
Further work is needed to define the role of corticosteroids in these conditions and until definitive studies are available, clinical judgment should be used in weighing the risks and benefits of corticosteroid use in treating influenza associated complications. For more information on management of influenza complications, please see the WHO revised guidance on Clinical Management of human infection with pandemic (H1N1) 2009.
1. Diaz E, Martin-Loeches I, Canadell L, Vidaur L, Suarez D, Socias L, et al. Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza. J Infect. 2012.
2. Martin-Loeches I, Lisboa T, Rhodes A, Moreno RP, Silva E, Sprung C, et al. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection. Intensive Care Med. 2011; 37(2): 272-83.
3. Brun-Buisson C, Richard JC, Mercat A, Thiebaut AC, Brochard L. Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med. 2011; 183(9): 1200-6.
4. Han K, Ma H, An X, Su Y, Chen J, Lian Z, et al. Early use of glucocorticoids was a risk factor for critical disease and death from pH1N1 infection. Clin Infect Dis. 2011; 53(4): 326-33.
5. Kim SH, Hong SB, Yun SC, Choi WI, Ahn JJ, Lee YJ, et al. Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores. Am J Respir Crit Care Med. 2011; 183(9): 1207-14.
6. Surviving Sepsis Campaign. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008.
7. Ito S, Shima S, Ueda A, Kawamura N, Asakura K, Mutoh T. Transient splenial lesion of the corpus callosum in H1N1 influenza virus-associated encephalitis/encephalopathy. Intern Med. 2011; 50(8): 915-8.
8. Kawashima H, Togashi T, Yamanaka G, Nakajima M, Nagai M, Aritaki K, et al. Efficacy of plasma exchange and methylprednisolone pulse therapy on influenza-associated encephalopathy. J Infect. 2005; 51(2): E53-6.
9. Munakata M, Kato R, Yokoyama H, Haginoya K, Tanaka Y, Kayaba J, et al. Combined therapy with hypothermia and anticytokine agents in influenza A encephalopathy. Brain Dev. 2000; 22(6): 373-7.
10. WHO Clinical management of human infection with pandemic (H1N1) 2009: revised guidance.
G_MICHIELI (aka IRONOREHOPPER)
Currently Active Users Viewing This Thread: 1 (0 members and 1 guests)
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
HTML code is On
The reader is responsible for discerning the validity, factuality or implications of information posted here, be it fictional or based on real events. Moderators on this forum make every effort to review the material posted on this site however, it is not realistically possible for our staff to manually review each post.
The content of posts on this site, including but not limited to links to other web sites, are the expressed opinion of the original authors or posters and are not endorsed by, or representative of the opinions of, the owners or administration of this website. The posts on this website are the opinion of the specific author or poster and should not be construed as statements of advice or factual information.
Not all posts on this website are intended as truthful or factual assertion by their authors. NO posts on this website should be considered factual information on face value alone. Users are encouraged to USE DISCERNMENT and do their own follow up research while reading and posting on this website. FluTrackers.com Inc. reserves the right to make changes to, corrections and/or remove entirely at any time posts made on this website without notice. In addition, FluTrackers.com Inc. disclaims any and all liability for damages incurred directly or indirectly as a result of a post on this website.
This site is provided "as is" without warranty of any kind, either expressed or implied. You should not assume that this site is error-free or that it will be suitable for the particular purpose which you have in mind when using it. In no event shall FluTrackers.com Inc. be liable for any special, incidental, indirect or consequential damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of use, data or profits, whether or not advised of the possibility of damage, and on any theory of liability, arising out of or in connection with the use or performance of this site or other documents which are referenced by or linked to this site.
Finally, FluTrackers.com Inc. reserves the right to delete, correct, or make changes to any post on this website without notice at any time for any reason.
Fair Use Notice:
This site may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. Users may make such material available in an effort to advance awareness and understanding of issues relating to public health, civil rights, economics, individual rights, international affairs, liberty, science & technology, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C.Section 107, the material on this site is distributed to those who have expressed a prior interest in receiving the included information for research and educational purposes.
In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 1 paragraph, and in no case more than 50% of the source material provide a link back to the original article and provide your original comments / criticism in your post with the article. Please remember you are responsible for what you post on the internet and you could be sued by the original copyright holder if you do not honor these rules.
If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your clients copyright
we may be contacted concerning copyright matters at:
c/o Sharon Sanders
1676 Hibiscus Avenue
Winter Park, Florida 32789
In accordance with section 512 of the U.S. Copyright Act our contact information has been registered with the United States Copyright Office. "Safe Harbor" noticing procedures as outlined in the DMCA apply to this website concerning all 3rd party posts published herein.
If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question.
All 3rd party material posted on this website is the copyright of the respective owners / authors. FluTrackers.com Inc. makes no claim of copyright on such material.
For more information please visit:
Please be aware any communications sent complaining about a post on this website may be posted publicly at the discretion of the administration.
FluTrackers Does Not Provide Any Medical Advice:
FluTrackers, Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster.
The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website.
By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
By using and/or accessing this site, either passively or actively, you are agreeing to all of the above conditions. Also, by using and/or accessing this site, either passively or actively, you agree to conduct all business and legal affairs related to this website in the jurisdiction of Flutrackers.com Inc. which is registered in Central Florida, USA.
These Disclaimers are subject to change at anytime.
Email the Webmaster with questions or comments about this site at firstname.lastname@example.org
All times are GMT -5. The time now is 10:14 PM.